Company news
Applied BioCode Corp. news in 2022
Applied BioCode Corp.'s news releases, calls and decks from 2022, newest first.
Applied BioCode: Announced the Company's Board Elected Chairperson
June 22, 2022
Applied BioCode: Announced the Appointment of Remuneration Committee Members resolved by the Board of Directors
June 22, 2022
The Company's Election of directors at the Company's 2022 Shareholders' General Meeting
June 13, 2022
Applied BioCode: Important resolutions of the Company's 2022 Shareholders' General Meeting
June 13, 2022
Announcement the Term Expired of Company's Remuneration Committee Members Due to the Election of Directors
June 13, 2022
Announcement the Change of the Company's Audit Committee Members
June 13, 2022
Applied BioCode: Announced the Company's 2022 Shareholders' General Meeting resolved the Release of non-compete restriction for newly elected directors
June 13, 2022
Announcement on behalf of subsidiary, Applied BioCode, Inc., signed an amended license and supply agreement with IDEXX Technologies GmbH
May 27, 2022
The Company's Board of Directors resolved to convene the 2022 Annual General Shareholders' Meeting (Location confirmed and electronic voting period amended)
April 28, 2022
At the request of TWSE, the Company announce related financial information
April 11, 2022
Applied BioCode Appoints Industry Veteran Chris Bernard as Chief Executive Officer
March 24, 2022
Applied BioCode Announces Exclusive Partner Distribution Agreement with Hardy Diagnostics, Further Broadens Reach of BioCode® MDx-3000 System into Hospitals and Reference Laboratories in the United States
March 14, 2022